News

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...
Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...
In my sixth year of Parkinson's, cognitive changes leave me wondering how much of this decline is due to the disease and how ...
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.
The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.
The Parkinson’s Support Group will meet at 6 p.m. July 17 at First Christian Church, 316 Ann St. The group will have snacks and sharing at 6 p.m. The meeting ...